EUVIMEDEUVIMED entdecken
Crossref

Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity

David Yardeni, Julianna Gershbaum Tobin, Bryan Itkowitz, Inna Lipnizkiy, Ali Abu Juma’a, Naim Abu-Freha, Ayelet Keren-Naus, May Turgeman, Anat Nevo-Shor, Robert Gareth Gish, Ohad Etzion

World Journal of Hepatology · 27.08.2026 · 18 (8)

DOI: 10.4254/wjh.124108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.08.2026. Verfasst von David Yardeni und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Despite the existence of an effective vaccine and treatment for the hepatitis B virus (HBV) more than 880000 people die each year from complications of cirrhosis and hepatocellular carcinoma associated with chronic HBV (CHB) infection. Limited information exists regarding the effect of antiviral treatment or the effect of patient background and viral factors on acute HBV outcome in a population with wide vaccine availability. Previous studies have demonstrated that widespread availability of the vaccine in developed countries has shifted the epidemiology of acute HBV infection to vulnerable subpopulations. AIM To evaluate the hypothesis that this epidemiologic shift in susceptibility of populations to acute HBV infection may alter the immune responses during acute infection and affect the rates of functional cure (FC) and viral persistence. METHODS We performed a retrospective evaluation of all patients above the age of 18 with acute HBV infection in Southern Israel between the years 2004-2022. Evaluated outcomes were FC, defined as hepatitis B surface antigen (HBsAg) clearance, or CHB infection defined as positive HBsAg at 6 months past the acute event. Clinical, biochemical, metabolic, and socioeconomic variables were analyzed. RESULTS Among 78 patients with acute HBV infection, 51 (65.3%) achieved FC, while 27 (34.6%) progressed to CHB infection. Patients who achieved FC had significantly higher peak alanine aminotransferase levels at presentation than those who developed CHB infection (2117 ± 1509 IU/mL vs 1103 ± 1540 IU/mL; P = 0.01). No differences in early initiation of nucleos(t)ide analogue therapy were found between patients who achieved FC and patients who developed CHB. Progression to CHB infection was significantly more common among patients with a background of low socioeconomic status (SES; 70% vs 41%; P = 0.04) and diabetes mellitus (DM; 26% vs 3.9%; P = 0.007). In univariable analysis, DM presence and a high SES were associated with a significant effect on HBsAg persistence (odds ratio = 8.57 and 0.46, respectively). CONCLUSION In the vaccination era, we postulate that acute HBV carries a higher-than-expected risk of chronicity, particularly among patients with metabolic disease and those from socioeconomic disadvantage backgrounds. Early risk stratification, targeted follow-up for high-risk cases, and further study of metabolic and social factors in FC are warranted.

Zitieren

APA

Yardeni, D., Tobin, J. G., Itkowitz, B., Lipnizkiy, I., Juma’a, A. A., Abu-Freha, N., Keren-Naus, A., Turgeman, M., Nevo-Shor, A., Gish, R. G., & Etzion, O. (2026). Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity. World Journal of Hepatology, 18(8). https://doi.org/10.4254/wjh.124108

Vancouver

Yardeni D, Tobin JG, Itkowitz B, Lipnizkiy I, Juma’a AA, Abu-Freha N, et al. Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity. World Journal of Hepatology. 2026;18(8). doi:10.4254/wjh.124108

BibTeX
@article{Yardeni2026,
  author = {Yardeni, David and Tobin, Julianna Gershbaum and Itkowitz, Bryan and Lipnizkiy, Inna and Juma’a, Ali Abu and Abu-Freha, Naim and Keren-Naus, Ayelet and Turgeman, May and Nevo-Shor, Anat and Gish, Robert Gareth and Etzion, Ohad},
  title = {Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity},
  journal = {World Journal of Hepatology},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4254/wjh.124108}
}
Kostenlos starten →